Oncogene deal

Robert Van Nostrand, vice president of finance and administration at ONCS, said the chemoprotectant agent will enter the clinic during the first quarter of 1994 and the wound healing product will be in the clinic by the end of 1994. ONCS will receive royalties on both products, he said. ...